The Kogenate Previously Untreated Patient Study Group: Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A - Safety, efficacy, and development of inhibitors - Lusher, J; Arkin, S; Abildgaard, C; Schwartz, R (N Engl J Med, 1993)